Thomas G P Bumm
Overview
Explore the profile of Thomas G P Bumm including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kouhestani D, Geis M, Alsouri S, Bumm T, Einsele H, Sauer M, et al.
Cell Mol Immunol
. 2020 Jul;
18(6):1568-1570.
PMID: 32709925
No abstract available.
2.
Banaszek A, Bumm T, Nowotny B, Geis M, Jacob K, Wolfl M, et al.
Nat Commun
. 2019 Nov;
10(1):5387.
PMID: 31772172
T cell-engaging immunotherapies are changing the landscape of current cancer care. However, suitable target antigens are scarce, restricting these strategies to very few tumor types. Here, we report on a...
3.
Agarwal A, Bumm T, Corbin A, OHare T, Loriaux M, VanDyke J, et al.
Blood
. 2008 Jun;
112(5):1960-70.
PMID: 18559973
BCR-ABL is proposed to impair cell-cycle control by disabling p27, a tumor suppressor that inhibits cyclin-dependent kinases. We show that in cell lines p27 expression is inversely correlated with expression...
4.
Bumm T, Elsea C, Corbin A, Loriaux M, Sherbenou D, Wood L, et al.
Cancer Res
. 2006 Dec;
66(23):11156-65.
PMID: 17145859
The JAK2(V617F) mutation is present in almost all patients with polycythemia vera (PV), large proportions of patients with essential thrombocythemia and idiopathic myelofibrosis, and less frequently in atypical myeloproliferative disorders...